May 8, 2012 - GenMark Diagnostics today reported financial results for the first quarter ended March 31, 2012.
April 5, 2012 - GenMark Diagnostics and Advanced Liquid Logic announced today that they have entered into a Heads of Agreement defining the key terms of a collaboration to develop an all-electronic, fully integrated in-vitro diagnostic platform bringing together ALL's proprietary electrowetting technology and GenMark's proprietary electrochemical detection.
April 2, 2012 - GenMark Diagnostics announced today that it has named Richard B. Slansky as Chief Financial Officer, effective April 23, 2012.
eSensor® XT-8 System
The eSensor® XT-8 system is the second generation in GenMark Dx’s eSensor platform, utilizing unique electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 is a complete benchtop system for making complex testing simple.
